Holen Sie sich die Stockscreener-App
1.92
3.03%
-0.06
Handel nachbörslich:
1.92
Schlusskurs vom Vortag:
$1.98
Offen:
$2.02
24-Stunden-Volumen:
1.17M
Relative Volume:
0.73
Marktkapitalisierung:
$1.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.93M
KGV:
-0.00721
EPS:
-266.137
Netto-Cashflow:
$-15.87M
1W Leistung:
-71.68%
1M Leistung:
-74.40%
6M Leistung:
-75.00%
1J Leistung:
-91.92%
1-Tages-Spanne:
$1.75
$2.04
1-Wochen-Bereich:
$1.75
$6.85
52-Wochen-Spanne:
$1.75
$66.33
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Firmenname
Transcode Therapeutics Inc
Sektor
Branche
Telefon
857-301-6857
Adresse
6 LIBERTY SQUARE, BOSTON
Vergleichen Sie RNAZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
1.92 | 1.36M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Transcode Therapeutics Inc Aktie (RNAZ) Neueste Nachrichten
The Significance of Moving Averages in TransCode Therapeutics Inc Inc. (RNAZ) Price Performance - The InvestChronicle
Transcode Therapeutics stock hits 52-week low at $2.62 By Investing.com - Investing.com South Africa
Transcode Therapeutics stock hits 52-week low at $2.62 - Investing.com
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com India
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - Investing.com UK
TransCode Therapeutics, Inc. Announces Results of Special Meeting - Yahoo Finance
Stock market news: China SXT Pharmaceuticals -92.51%, TransCode Therapeutics -37.91% among biggest losers during midday trading - Business Upturn
Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast - Benzinga India
Learn to Evaluate (RNAZ) using the Charts - Stock Traders Daily
TransCode reports positive phase 1 trial progress for cancer therapy - MSN
(RNAZ) Technical Data - Stock Traders Daily
Clinical Trials News Live Feed - StockTitan
RNAZ’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
The -45.19% Simple Moving Average of TransCode Therapeutics Inc’s (RNAZ) Stock in the Past 200 Days - The News Heater
The Impact of Market Fluctuations on ChargePoint Holdings Inc’s (CHPT) Stock - The News Heater
Market Analysts see Helmerich & Payne, Inc [HP] falling to $39. Time to buy? - The DBT News
Wag Group Co [PET] Revenue clocked in at $76.75 million, up 36.38% YTD: What’s Next? - The DBT News
Wall Street Analyst Reiterated Gamestop Corporation [GME]. What else is Wall St. saying - The DBT News
Shoals Technologies Group Inc [SHLS] Stock trading around $4.60 per share: What’s Next? - The DBT News
Ensysce Biosciences (NASDAQ:ENSC) Stock Quotes, Forecast and News Summary - Benzinga
Cronos Group Inc [CRON] fell 0.00% so far this year. What now? - The DBT News
Northern Dynasty Minerals Ltd [NAK] is 26.40% higher this YTD. Is it still time to buy? - The DBT News
For Coupang Inc [CPNG], Analyst sees a rise to $30. What next? - The DBT News
Market Analysts see BBB Foods Inc [TBBB] gaining to $32. Time to buy? - The DBT News
why Borr Drilling Ltd [BORR] is a Good Choice for Investors After New Price Target of $5.23 - The DBT News
American Superconductor Corp [AMSC] Stock trading around $34.24 per share: What’s Next? - The DBT News
Callan JMB Inc [CJMB] gain 54.15% so far this year. What now? - The DBT News
Wall Street Analyst Resumed Equillium Inc [EQ]. What else is Wall St. saying - The DBT News
why Silexion Therapeutics Corp [SLXN] is a Good Choice for Investors After New Price Target of $9.00 - The DBT News
SNDL Inc [SNDL] Is Currently 3.76 above its 200 Period Moving Avg: What Does This Mean? - The DBT News
Envista Holdings Corp [NVST] moved up 5.93: Why It’s Important - The DBT News
2 Top Fintech Stocks to Buy in February - The Globe and Mail
Wall Street Analyst Resumed Lilly[Eli] & Co [LLY]. What else is Wall St. saying - The DBT News
Health In Tech Inc [HIT] Revenue clocked in at $19.80 million, down -0.84% YTD: What’s Next? - The DBT News
AEON Biopharma Inc [AEON] Stock trading around $0.14 per share: What’s Next? - The DBT News
Stocks of TransCode Therapeutics Inc (RNAZ) are poised to climb above their peers - SETE News
TransCode Therapeutics (NASDAQ:RNAZ) Receives Buy Rating from HC Wainwright - Armenian Reporter
Insider Buying: Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Director Purchases $103,200.00 in Stock - Armenian Reporter
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Stock market today: Lipella Pharmaceuticals +99.22%, Digital Turbine +68.90% among top gainers in early trading - Business Upturn
Transcode Therapeutics completes Cohort 3 dosing in Phase 1 trial of TTX-MC138 - TipRanks
TransCode reports positive phase 1 trial progress for cancer therapy By Investing.com - Investing.com UK
TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial - PR Newswire
TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting - Longview News-Journal
How Is The Market Feeling About TransCode Therapeutics? - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Stock market news: TransCode Therapeutics +133.97%, Diginex +27.49% among top gainers during mid day trading - Business Upturn
Are Investors Keen On Selling Holdings In GSK Plc ADR (NYSE: GSK)? - Stocks Register
Dow Inc (NYSE: DOW) Is A Buzzing Hot Stock - Stocks Register
Stock market today: Sentage Holdings +70.79%, Planet Image International +64.29% among top gainers in early trading - Business Upturn
Finanzdaten der Transcode Therapeutics Inc-Aktie (RNAZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.45%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):